MSMichel Sabé

Michel Sabé

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michel Sabé has a total of 214 co-authors. Here are the top co-authors by number of shared publications:

  • Stefan Kaiser

    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, Chemin Du Petit-Bel-Air, Thonex, CH-1226, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland

    12 shared publications
  • Marco Solmi

    Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; Department of Mental Health, The Ottawa Hospital, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

    10 shared publications
  • Marco Solmi

    SCIENCES Lab, Department of Psychiatry, University of Ottawa, Ottawa, ON K1N 6N5, Canada

    10 shared publications
  • Othman Sentissi

    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, Chemin du Petit-Bel-Air, Thônex CH-1226, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland

    8 shared publications
  • Stefan Kaiser

    Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland

    8 shared publications
  • Kerem Böge

    Department of Psychiatry and Neurosciences, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Berlin, 10117, Germany

    7 shared publications

Latest Publications

  • Open Access

    Social deprivation in schizophrenia spectrum disorders: A systematic review

    by Silvia Monari, Luigi F. Saccaro, Matthias Kirschner, Stefan Kaiser, Silvia Bolano, Michel Sabé

  • Open Access

    Psychedelic-induced hypomania and mania: a systematic review and meta-analysis

    by Mickael Eskinazi, Rayan Nasserdine, Romane M. Cusin, Pantelis Baniotoupoulos, Luigi F. Saccaro, Marco De Pieri, Tamara Corino, Federico Seragnoli, Jean-Francois Briefer, Tatiana Aboulafia Brakha, et al.

    Serotonergic psychedelics are increasingly investigated as treatments for affective disorders. Concerns persist regarding their potential to induce hypomania or mania, particularly in individuals with bipolar spectrum vulnerability. Whether these substances precipitate transient mood switches or contribute to persistent bipolar illness or diagnostic transition remains unclear. We conducted a systematic review of human studies examining manic or hypomanic symptoms following exposure to serotonergic psychedelics (psilocybin, LSD, mescaline, DMT/ayahuasca) or MDMA (CRD420251160656). Databases and trial registries were searched through January 26, 2026. Eligible designs included randomized and non-randomized clinical studies, registry-based cohorts, cross-sectional surveys, and longitudinal observational studies. Outcomes included dysphoria/euphoria, manic or hypomanic symptoms and transition to bipolar disorder. Risk of bias was assessed using ROBINS-I, ROB2 or NIH tools. Twenty-three studies met inclusion criteria, four contributing to meta-analysis. Rates of psychedelic-associated dysphoria/euphoria, hypomania or mania ranged from 5.8% in controlled trials of psilocybin-assisted psychotherapy for major depressive disorders to 30% in naturalistic studies of individuals with bipolar disorder. When present, manic symptoms were typically acute and self-limited. Observational studies identified higher risks among individuals with bipolar I disorder, familial vulnerability, polysubstance use, and unsupervised or illegal use. Registry-based cohorts examining diagnostic transitions showed a prevalence of subsequent transition to bipolar disorder of 4% (95% CI 2–8%; N = 7478; I² = 32.1%), with little evidence for a hallucinogen-specific signal. Overall, serotonergic psychedelics appear to pose a low but clinically meaningful relative risk of transient mood-related symptoms in susceptible individuals while remaining relatively safe in controlled clinical settings. Long-term outcomes and repeated exposure remain insufficiently studied, underscoring the need for rigorous longitudinal research.


  • Open Access

    Guidance List for repOrting Bibliometric AnaLyses (GLOBAL): Explanation and Elaboration

    by Jeremy Y. Ng, Niveen Syed, Dalia Zubashev, Mehvish Masood, Henry Liu, Michel Sabé, Marco Solmi, Dimity Stephen, Jens Peter Andersen, Lutz Bornmann, et al.

    Background : Bibliometric analysis is a valuable approach for studying and evaluating scholarly communication, research output and impact, collaboration patterns, and knowledge flows by examining various aspects of scholarly works across different levels of actors and aggregations. Despite the strong growth in publications using bibliometrics, there is limited guidance on how to report bibliometric analyses. The lack of standardized reporting practices has led to the creation of the Guidance List for the repOrting of Bibliometric AnaLyses (GLOBAL) . This evidence-based guideline, developed via the EQUATOR Network’s framework, aims to provide a systematic approach to reporting bibliometric analyses in scholarly literature with the ultimate goal of improving reporting quality. This Explanation and Elaboration (E&E) document is a supplementary document intended to facilitate the use of the GLOBAL. Methods : This E&E document was modeled after similar documents prepared for other reporting guidelines, such as Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and Consolidated Standards of Reporting Trials (CONSORT). It includes feedback from Delphi participants and steering committee members, as well as references from peer-reviewed research papers. The GLOBAL steering committee, which supervised and provided input to the GLOBAL’s development, consisted of six international researchers, four with expertise in bibliometrics (LW, MSabé, MSolmi, and SH) and two with expertise in reporting guidelines (DM and JYN). This document underwent pilot-testing and iterative processes of editing to enhance its clarity and applicability. Results: This document includes detailed explanations and examples that satisfy the checklist items. Each item has an expanded explanation where the necessary components and rationale of the checklist items are presented, alongside practical examples. These examples are extracted from published bibliometric literature and provide authors with a framework on how to approach the reporting of their analyses when following the GLOBAL. Conclusion: The GLOBAL is designed to guide the reporting of bibliometric analyses with a particular focus on manuscript-style publications (including journal and conference papers), encouraging more transparent reporting of studies using bibliometric methods. The supplementary document aims to assist in the adoption of the GLOBAL by providing explanations and examples on its implementation.


  • Open Access

    Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review

    by Michel Sabé, Paul Grof, Nathan B. Sackett, Sara Tai, Pamela Kryskow, Anya Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos, et al.


  • Top Cited Papers
    Open Access

    Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland

    by T. Aboulafia-Brakha, A. Buchard, C. Mabilais, S. Alaux, C. Amberger, L. Furtado, F. Seragnoli, J-F Briefer, G. Thorens, M. Sabé, et al.


  • Psychological Interventions for Persons With Co-occurring Psychotic and Traumatic-Stress Symptoms: A Systematic Review and Meta-analysis

    by Helen Niemeyer, Felix Opper, Michel Sabé, Emily A Holmes, Kerem Böge

    Background and Hypothesis: Psychotic and traumatic-stress symptoms commonly co-occur. Psychological interventions have increasingly targeted these co-occurring symptoms. However, information on their efficacy, tolerability, and acceptability is limited in this evolving field. Study Design: After preregistration at PROSPERO (CRD42024553934), we conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) of psychological interventions with persons aged 16+ reporting both psychotic and traumatic-stress symptoms. PubMed, CINAHL, Embase, PsycINFO, Clinicaltrials.gov, and Web of Science were searched in July 2024. We used the Revised Cochrane Risk-of-Bias Tool for Randomized Trials (RoB-2) for bias assessment. Random-effects models were used to synthesize clinical outcomes, while meta-regression was applied when 10 effect sizes were reported per outcome. Study Results: We included 10 RCTs with 559 participants. Interventions primarily targeted trauma-related symptoms and were seemingly tolerable and acceptable, with low adverse event profiles and a dropout rate of 14%. In comparison to usual treatments and active control treatments, interventions significantly decreased traumatic-stress symptoms at post-treatment (g = 0.33, 95% CI [0.08, 0.57]), with meta-regression favoring interventions primarily employing exposure (gdiff = 0.59, [0.22, 0.97]). Interventions significantly decreased traumatic-stress symptoms at follow-up (g = 0.34, [0.12, 0.56]), but not total psychotic, positive, or negative symptoms at either timeframe. Conclusions: Findings suggest that psychological interventions for co-occurring psychotic and traumatic-stress symptoms are safe, tolerable, and may reduce traumatic-stress symptoms when employing exposure. Considering the substantial risk of bias, the small number of trials, non-significant results for other clinical and functional outcomes, and unexplained heterogeneity, further research is needed.


  • Top Cited Papers
    Open Access

    Guidance for the reporting of bibliometric analyses: A scoping review

    by Jeremy Y. Ng, Henry Liu, Mehvish Masood, Niveen Syed, Dimity Stephen, Ana Patricia Ayala, Michel Sabé, Marco Solmi, Ludo Waltman, Stefanie Haustein, et al.

    Despite the growth in the number of bibliometric analyses published in the peer-reviewed literature, few articles provide guidance on methods and reporting to ensure reliability, robustness, and reproducibility. Consequently, the quality of reporting in existing bibliometric studies varies greatly. In response, we are developing a preliminary Guidance List for the repOrting of Bibliometric AnaLyses (GLOBAL), a reporting guideline for bibliometric analyses. This paper outlines a scoping review that aims to identify and categorize bibliometric recommendations from the literature to develop an initial list of candidate items for GLOBAL. Five bibliographic databases, three preprint servers, and gray literature were systematically searched. Twenty-three out of 48,750 records fulfilled the inclusion criteria. Six documents contained bibliometric reporting recommendations based on a complete or partial literature review; all other sources (n = 17) contained opinion-based recommendations. A 32-item recommendation list that will inform the development of GLOBAL was created. A paucity of evidence-based studies on bibliometric reporting exists in the literature, supporting the need to create a reporting guideline for bibliometric analyses. The next step in GLOBAL project will focus on conducting a two-round Delphi study to achieve consensus on which of the 32 items should be included in GLOBAL.


  • Open Access

    Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia

    by Jacopo Sapienza, Marco Spangaro, Stefano Comai, Michel Sabé, Joseph La Torre, Matteo Buonarroti, Roberto Cavallaro, Marta Bosia

    Schizophrenia is a highly polygenic disease, and several genetic variants associated with the disease converge on altered synaptic homeostasis. In particular, the gene encoding complement component 4 (C4) showed the strongest association with schizophrenia, and this protein is involved in complement-dependent and microglia-mediated synaptic pruning. As a matter of fact, microglia are overactive in schizophrenia, and reduced synaptic arborization, especially in the prefrontal cortex (PFC), is an established hallmark of schizophrenia, likely associated with gray matter loss, cortical thinning, hypofrontality, and deficit syndrome. The recent development of a new radioligand targeting the synaptic vesicle glycoprotein 2A (SV2A) demonstrated in vivo lower synaptic density at the PFC level in individuals with schizophrenia, corroborating the synaptic hypothesis of thedisease first proposed by Feinberg in 1982. Interestingly, robust preclinical evidence (in vitro and animal models) showed the ability of psychedelics to promote neuroplasticity and synaptogenesis, potentially counteracting the excessive synaptic loss, restoring volume loss, and possibly explaining improvements in negative and cognitive symptoms described by old clinical studies. Overall, microdoses should be explored first as a possible treatment in a selected sample of patients affected by deficit schizophrenia, followed by low and full doses if encouraging results were to emerge.


  • Open Access

    Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review

    by Adi Sulstarova, Luise Scheuerlein, Silvia Monari, Federico Seragnoli, Thorens Gabriel, Katrin Preller, Kerem Böge, Othman Sentissi, Stefan Kaiser, Marco Solmi, et al.


  • Open Access

    Half a Century of Research for Mind–Body Interventions: A Scientometric Analysis

    by Michel Sabé, Chaomei Chen, Davy Vancampfort, Joseph Firth, Lee Smith, Brendon Stubbs, Simon Rosenbaum, Felipe Barreto Schuch, Paco Prada, Luigi Francesco Saccaro, et al.

    Objectives: We conducted a scientometric analysis on mind–body interventions to assess themes and trends in recent decades, providing insights for prospective research directions. Our systematic search, completed on 1 November, 2023, encompassed the Web of Science Core Collection and focused on scientific publications related to contemplative practices: Mindfulness, Yoga, Qi-gong, Tai-chi, Vipassana, Zen, Loving-kindness, and Transcendental meditation. Method: Integration of network analyses and bibliometrics using Bibliometrix and CiteSpace allowed us to identify evolving research themes. Our primary objective was to measure the evolution of research trends, while secondary aims involved uncovering influence networks tied to countries, publications, institutions, and authors. Co-citation reference networks specific to each mind–body practice were extracted. Results: Our analysis incorporated 16,310 documents (389,632 references) spanning the years 1973 to 2023, forming a well-structured network with credible clustering. The overarching dataset highlighted the dominance of mindfulness practice in the realm of mind–body interventions. To further explore research patterns, we explored individual co-citation reference networks for each practice, revealing varying sizes for Mindfulness (n = 2278), Yoga (n = 1303), Qi-gong (n = 582), Tai-chi (n = 1000), Vipassana (n = 344), Zen (n = 454), Loving-kindness (n = 552), and Transcendental meditation (n = 834). Each practice exhibited distinct clusters, focusing on applications for diverse mental disorders and physical health issues, ranging from substance abuse to schizophrenia, and from back pain to dementia. Conclusions: While research on mind–body interventions has been predominantly influenced by mindfulness in recent decades, each type of mind–body intervention contributes uniquely to both theoretical and clinical contexts. These insights have significant implications for funding agencies and research groups, guiding future directions in the field. Preregistration: The preregistered protocol can be found online (https://osf.io/qzb3c/).